海角乱伦社区

Richard Addo

Professor of Pharmaceutical Sciences

43 Results

Book(s), Monograph(s) or Book Chapter(s)

Peer-Reviewed Journal Article(s)

• "Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.," Nanomedicine (Lond), 10(15), 2405-22. (August 2015) (with Rahman M, Akhter S, Ahmad MZ, Ahmad J, Ahmad FJ, Pichon C.)
• "Formulation and characterization of atropine sulfate in albumin-chitosan microparticles for in vivo ocular drug delivery.," J Pharm Sci., 104(5), 1677-90. (May 2015) (with Yeboah KG, Siwale RC, Siddig A, Jones A, Ubale RV, Akande J, Nettey H, Patel NJ, Addo E, D'Souza MJ.)
• "Development and Validation of a UPLC Method for Rapid and Simultaneous Analysis of Proton Pump Inhibitors.," AAPS PharmSciTech, 16 (1), 30-4. (February 2015) (with Davis KR, Ubale R, Owen JS and Watkins EB.)
• "Solid Matrix Based Lipidic Nanoparticles in Oral Cancer Chemotherapy: Applications and Pharmacokinetics," Curr Drug Metab., 16(8), 633-44. (January 2015) (with Ahmad J, Amin S, Rahman M, Rub RA, Singhal M, Ahmad MZ, Rahman Z, Ahmad FJ, Mushtaq G, Kamal MA, Akhter S.)
• "The effect of antisense to NF-?B in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats.," J Drug Target, 22(9), 796-804. (November 2014) (with Patel N, Ubale R, Uddin MN, D'Souza M, and Jobe L)
• "In vitro and ex vivo characterization of lectin-labeled Mycobacterium tuberculosis antigen-containing microspheres for enhanced oral delivery," J Drug Target, 22(1), 34-47. (January 2014) (with Yeboah KG, Akande J, Siwale RC, Aninkorah-Yeboah K, Siddig A)
• "Formulation and characterization of novel riboflavin containing albumin/glycine microspheres," International Journal of Pharmacy and Integrated Life Sciences. (August 2013) (with Siddig A, Musik L, Oyelowo O, Sun X, Yeboah KG)
• "Response to 鈥楾he need to evaluate question writers' views and the costs of constructed-response versus selected-response calculations questions鈥�," Am J Pharm Educ. , 77 (4), 87. (May 2013) (with Sheaffer EA)
• "Evaluation of over the counter vaginal lubricants nonoxymol-9 and KY Jelly as potential inducer of proinflammatory cytokines in human immune cells," European Journal of Chemistry. (May 2013) (with Aladin Siddig, Kwame Yeboah)
• "Pharmacy student performance on constructed-response versus selected-response calculations questions," Am J Pharm Educ., 77 (1), 6. (February 2013) (with Sheaffer EA)
• "End of Supply Chain Screening to Assess Drug Product Quality in the U.S. Market 鈥� Omeprazole as a Case Study," Advances in Analytical Chemistry, 3(4), 48-53. (January 2013) (with E. Blake Watkins, Joel S. Owen, Kenneth R. Davis, Ronald C. Bingham)
• "Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas," Journal of Drug Targeting, 19(6), 427-33. (July 2011) (with Jones AK, Bejugam NK, Nettey H, and D'Souza MJ)
• "Targeted Delivery of Antigens to the Gut-Associated Lymphoid Tissues: 2. Ex vivo Evaluation of Lectin-labeled Albumin Microspheres for Targeted Delivery of Antigens to the M cells of the Peyer鈥檚 Patch," Journal of Microencapsulation, 27(4), 325-36. (January 2010) (with Akande J, Yeboah KG, Siddig A, Oettinger CW, D'Souza MJ)
• "Formulation, Characterization, and Testing of Tetracane Hydrochloride-Loaded Albumin-Chitosan Microparticles for Ocular Drug Delivery," Journal of Microencapsulation, 27(2), 95-104. (January 2010) (with Siddig A., Patel N.J., Siwale R., Akande J., Uddin A.U., and D鈥橲ouza M.J.)
• "The effect of intracellular antioxidant delivery (catalase) on hydrogen peroxide and pro-inflammatory cytokine synthesis: a new therapeutic horizon," Journal of Drug Targeting, 17(9), 710-8. (November 2009) (with Siwale, Rodney C; Oettinger, Carl W; Yeboah, George K; D'Souza, Martin J)
• "The effect of intracellular delivery of catalase and antisense oligonucleotide to NF-kappaB using albumin microcapsules in the endotoxic shock model," Journal of Drug Targeting, 17(9), 701-9. (November 2009) (with Siwale, Rodney C; Oettinger, Carl W; Siddig, Aladin; D'Souza, Martin J)
• "Formulation and characterization of catalase in albumin microspheres," J Microencapsul, 23, 1-9. (September 2008) (with Siwale RC, Oettinger CW, Balakrishna Pai S, Uddin N, Siddig A, D'Souza MJ)
• "Treatment of adjuvant arthritis using microencapsulated antisense NF-kappaB oligonucleotides," J Microencapsul, 18, 1-12. (July 2008) (with Akhavein N, Oettinger CW, Gayakwad SG, Bejugam NK, Bauer JD, Do D, Pollock SH, D'souza MJ Akhavein)
• "," ()

Presentation(s)

• "Needleless Measles Vaccine Delivery: Preclinical Evaluation of Oral Disintegrating Films in a Juvenile Pig Model" (with Gala RP., Popescu C., Knipp GT., McCain RR., Ubale RV., Bhowmik T., and. D鈥橲ouza MJ)
  AAPS Meeting, Orlando, FL. (October 2015)
• "Ex Vivo Evaluation of Inhibition of LPS-Induced Choroidal Neovascularization into the Retinal Epithelium with Antioxidant Thymoquinone in L-a Phosphatidylcholine-Chitosan Microparticles" (with Rodney S.)
  AAPS Meeting, Orlando, FL. (October 2015)
• "Development of Nano-Sized Particles Containing Anti-Oxidant for the Treatment of Age-Related Macular Degeneration (AMD)" Union University PEW Luncheon, Jackson, TN. (April 2015)
• "Development and Validation of a UPLC Method for Rapid and Simultaneous Analysis of Proton Pump Inhibitors." (with Davis, K.; Ubale, R.; Owen, J.; and Watkins, E. B.)
  American Association of Pharmaceutical Scientists Annual Meeting and Exposition, San Diego, CA. (November 2014)
• "Formulation and Characterization of Thymoquinone-Loaded Microparticles for Treatment of Age Related Macular Degeneration." (with Ubale R.)
  American Association of Pharmaceutical Scientist, Annual Conference, San Diego, CA. (November 2014)
• "Ocular Delivery of peptides and proteins." 5th World Congress on Biotechnology, Valencia, Spain, . (June 2014)
• "Formulation and Characterization of Albumin/Glycine Microspheres Encapsulated with Riboflavin as a model drug" AAPS at the McCormick Place, Chicago, IL. (October 2012)
• "Formulation, Characterization and in vitro evaluation of Resveratrol Loaded Glycine Microspheres." (with Siddig, K. Yeboah)
  AAPS Annual Meeting, Washington, DC. (October 2011)
• "Formulation of Cross-linked Albumin Nanospheres via the One Step Spray Drying Process" (with N.J. Patel, S.G. Gayakwad, and M.J. D鈥橲ouza)
  3rd Annual Georgia Nanotechnology and Infectious Disease Symposium, Atlanta, GA. (April 2011)
• "A Comparative Study of Question Types in Pharmaceutical Calculations and Pharmaceutics" (with Sheaffer EA)
  AACP Annual Meeting, Seattle, WA. (July 2010)
• "Development and Validation of HPLC Assay for Prednisolone in Pluronic Lecithin Organogel (PLO) Stability Study" (with McDonald, Edward G.)
  Shenandoah University Research Symposium, Winchester, VA. (April 2010)
• "Development and Validation of Stability-indicating HPLC Method to Determine the Stability of Promethazine in Pluronic Lecithin Organogel (PLO)" (with Uliana Samantha)
  Shenandoah University Research Symposium, Winchester, VA. (April 2010)
• "To quantitatively establish ketoprofen stability in PLO by developing and validating a stability-indicating HPLC method." (with Beitman, Meghan E)
  Shenandoah University Research Symposium, Winchester, VA. (April 2010)
• "The Effects of Sustained Release NF-kB Anti-Sense Microencapsulated Albumin Microspheres on Left Ventricular Remodeling Associated with Chronic Volume Overload in Rats" (with Patel N.J., Keys B., Gayakwad S., Akhavein N., D鈥橲ouza M.J., and Jobe L.)
  American Association of Pharmaceutical Scientists, Annual Conference, Atlanta, GA. (November 2008)
• "Evaluation of the effect of microencapsulated antisense oligonucleotide to NF-KB on B-16 melanoma-induced tumor development and regression" (with Akande J. M., Siddig A., Akhavein N., D'Souza M.)
  American Association of Pharmaceutical Scientists, Annual Conference, Atlanta, GA. (November 2008)
• "Evaluation of microparticulate based atropine formulations for its mydriatic effect" (with Siddig A., D'Souza M.J.)
  American Association of Pharmaceutical Scientists, Annual Conference, Atlanta, GA. (November 2008)
• "Evaluation of the effect of tetracaine microparticles formulations" (with Siddig Aladin, D鈥橲ouza Martin)
  American Association of pharmaceutical Scientist, Annual Conference, San Diego, CA. (November 2007)
• "Evaluation of the effect of the microencapsulated anti-sense oligonucleotide to NF-kappaB on tumor development and regression" (with Akande Janet, Siddig Aladin, D鈥橲ouza Martin)
  American Association of pharmaceutical Scientist, Annual Conference, San Diego, CA. (November 2007)

Award/Recognition(s)

• Research Grant 鈥� Addo, RT and Ubale R. 鈥淒evelopment of Nano-sized Particles Containing Anti-oxidant for the Treatment of Age Related Macular Degeneration鈥�. Funded by Union University Pew Research Program (Principal Investigator), 2013
• Grant 鈥� Addo RT, Watkins EB, Owen JS. Accelerated Stability Testing of Compounded Drugs 鈥淎 Research Proposal to evaluate the stability of various compounded drugs and assigning the BUD to the preparation鈥� 鈥� amount $5141.70. Betamethasone Sodium Phosphate /Betamethasone Acetate drug Suspension funded on August 2012 by Main street Pharmacy, Newbern TN 鈥� (Principal Investigator), 2012
• Research Grant Addo R.T., Owen J.S., Watkins E.B., Phillip A., 鈥淚s there Medicine in the Medicine?鈥� A Research Proposal to evaluate marketed products for drug content. Ronald Bingham, M.D., EMG Clinics of Tennessee. PLLC. $11,270.64, 2012
• Research Grant Peacock, G, Addo, RT. 鈥淭he Stability of Various (five different) Drugs Compounded in PLO gel鈥�, IACP, International Academy of Compounding Pharmacist, $9,400.00, 2010
• Outstanding Poster and Presentation Award o Outstanding Poster and Presentation Award Winner at Graduate Research Association of Students of Pharmacy (GRASP), Florida A. and M. University, Tallahassee, Florida on June 7, 2008. Poster entitled "Development and Evaluation of Microparticulate Based Atropine Formulations for its Mydriatic Effect", 2008

Dissertation

• "Development and Characterization of Novel Encapsulated Ocular Drug Delivery Formulations" (January 2008)